Regeneron Pharmaceuticals Inc. is looking for ways to put its vast drug discovery and development machinery to work on behalf of start-ups that don't have the resources to build those capabilities on their own. Through that effort, it negotiated a novel collaboration with hearing-focused Decibel Therapeutics.
The deal's structure is unique: Regeneron will make an equity investment in Decibel and provide financial support for research and...








